Global Open-Angle Glaucoma Therapeutics Market

1. Summary

The Global Open-Angle Glaucoma Therapeutics Market was valued at $6.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.4% CAGR, to an estimated market size of $8.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Open-Angle Glaucoma Therapeutics market encompasses pharmaceutical treatments, sustained-release drug delivery systems, and therapeutic interventions designed to manage intraocular pressure (IOP) and prevent irreversible damage to the optic nerve. The scope includes various drug classes such as prostaglandin analogs, beta-blockers, and alpha-agonists, while excluding standalone surgical hardware not integrated with drug delivery.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Open-Angle Glaucoma Therapeutics Market in the period 2025-30:

• The aging global population is significantly increasing the prevalence of open-angle glaucoma, driving long-term demand for chronic therapeutic management.
• A major shift toward sustained-release drug delivery systems, such as intracameral implants, is addressing the challenge of patient non-compliance associated with daily eye drops.
• The integration of Minimally Invasive Glaucoma Surgery (MIGS) with pharmacological treatments is creating a new paradigm for managing moderate disease progression.
• Advancements in Artificial Intelligence (AI) and digital imaging are improving early diagnostic accuracy and enabling more personalized treatment monitoring.
• The market is seeing a rise in fixed-dose combination therapies which simplify treatment regimens and improve patient adherence compared to multiple separate medications.
• Significant R&D investment is flowing into neuroprotective agents and gene therapies that aim to protect retinal ganglion cells independently of intraocular pressure reduction.
• The increasing availability of generic formulations for established drugs is expanding market access in emerging economies while pressuring branded revenue in mature markets.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: